KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC - JUNO THERAPEUTICS INC ownership

Back to all holdings Add to watchlist

JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.

Links
Filings
External links
Quarter-by-quarter ownership
KAYNE ANDERSON RUDNICK INVESTMENT MANAGEMENT LLC ownership history of JUNO THERAPEUTICS INC
ValueSharesWeighting
Q4 2017$1,852,000
+2.0%
40,510
+0.1%
0.02%
-6.2%
Q3 2017$1,815,000–40,453–0.02%–
 Download
Other shareholders

There were no reported owners of JUNO THERAPEUTICS INC in Q3 2017.

NameSharesValueWeighting ↓
View complete list of JUNO THERAPEUTICS INC shareholders